Moonhealth SIL SA
BBME:SL03013.04
EUR
+0.00
(+0.02%)
ISIN
ES0164452007
Return %
Stock
S&P 500
1Y
7.21
14.20
3Y
35.29
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Madrid Spain
- Similar Companies
- Business
- Moonhealth SIL SA is a Spain-based collective investment company (Sociedad de Inversión Libre) specializing in strategic alternative asset management and equity investments within the healthcare, biotechnology, life sciences, and medical technology sectors. Headquartered in Madrid, Spain, the company operates as an alternative investment vehicle designed to identify, finance, and accelerate growth-oriented enterprises and high-value assets across the healthcare and wellness ecosystem. The company's primary business activities and investment portfolio solutions include: direct venture capital and private equity investments in early-stage to growth-stage healthtech, medical device, and biopharmaceutical enterprises; equity and quasi-equity funding for clinical research, laboratory diagnostics, and specialized therapeutic developers; capital deployment into digital healthcare platforms, remote patient monitoring infrastructure, and health data management solutions; strategic asset holdings in healthcare-related real estate and specialized medical facilities; and customized portfolio management strategies focused on liquid and illiquid global healthcare financial instruments. Moonhealth SIL SA conducts its investment operations primarily across Spain and broader European markets, targeting high-growth segments driven by structural demographic shifts, healthcare digitalization, and therapeutic innovation. The company serves qualified institutional investors, family offices, and high-net-worth investors seeking dedicated thematic exposure to the healthcare industry, operating in compliance with Spanish collective investment regulations and capital market oversight. In recent developments, Moonhealth SIL SA completed its listing and admission to trading on the BME Scaleup market of Bolsas y Mercados Españoles under the ticker symbol SL030, marking a major milestone in enhancing its corporate visibility, institutional governance, and liquidity profile. Over the past two years, the company has executed capital increases to expand its investable capital base, entered into strategic co-investment alliances with specialized European life sciences funds and healthcare technology accelerators, and broadened its portfolio through new allocations in artificial intelligence-enabled diagnostic systems and advanced clinical care solutions. Additionally, the company has integrated enhanced sustainability and ESG criteria into its asset selection processes to capture emerging opportunities in modern European health infrastructure.